3-Bromo-1H-pyrrolo[2,3-c]pyridine-4-carbonitrile
97%
- Product Code: 140788
CAS:
1190310-21-4
Molecular Weight: | 222.04 g./mol | Molecular Formula: | C₈H₄BrN₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme active sites, making it valuable in creating targeted therapies. Commonly utilized in medicinal chemistry for constructing complex heterocyclic systems found in bioactive molecules. Also employed in research settings to develop new neuroprotective agents and anti-inflammatory drugs due to its ability to modulate cellular signaling pathways.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿14,410.00 |
+
-
|
1g | 10-20 days | ฿66,040.00 |
+
-
|
3-Bromo-1H-pyrrolo[2,3-c]pyridine-4-carbonitrile
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme active sites, making it valuable in creating targeted therapies. Commonly utilized in medicinal chemistry for constructing complex heterocyclic systems found in bioactive molecules. Also employed in research settings to develop new neuroprotective agents and anti-inflammatory drugs due to its ability to modulate cellular signaling pathways.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :